Progress of chimeric antigen receptor T-cell therapy in treatment of hematological malignancies / 白血病·淋巴瘤
Journal of Leukemia & Lymphoma
;
(12): 310-312, 2020.
Artículo
en Chino
| WPRIM
| ID: wpr-862839
ABSTRACT
Chimeric antigen receptor T-cell (CAR-T) therapy is effective in treating lymphoma and leukemia. A large number of basic and clinical studies have led to the rapid development of CAR-T therapy. This paper reviews the concept of CAR-T therapy, the application of CAR-T in hematologic diseases, and the problems and solutions of CAR-T.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Journal of Leukemia & Lymphoma
Año:
2020
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS